These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6358210)

  • 21. Staphylococcus aureus adherence to thrombin-treated endothelial cells is mediated by fibrinogen but not by platelets.
    Shenkman B; Rubinstein E; Tamarin I; Dardik R; Savion N; Varon D
    J Lab Clin Med; 2000 Jan; 135(1):43-51. PubMed ID: 10638693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets.
    Greenberg CS; Shuman MA
    J Biol Chem; 1984 Dec; 259(23):14721-7. PubMed ID: 6150044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between platelets and coagulation factors in hemostasis.
    Majerus PW; Miletich JP
    Annu Rev Med; 1978; 29():41-9. PubMed ID: 348040
    [No Abstract]   [Full Text] [Related]  

  • 24. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The binding of fibrinogen to platelets in diabetes mellitus.
    di Minno G; Cerbone AM; Iride C; Mancini M
    Wien Klin Wochenschr; 1986 Apr; 98(7):217-21. PubMed ID: 3010580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
    Plow EF; Pierschbacher MD; Ruoslahti E; Marguerie GA; Ginsberg MH
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8057-61. PubMed ID: 3877935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of a platelet component to endothelial prostacyclin production despite inhibition of platelet cyclooxygenase activity.
    Czervionke RL; Hoak JC; Haycraft DL; Fry GL; Mann KG
    Trans Assoc Am Physicians; 1982; 95():272-9. PubMed ID: 6820742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments.
    Tollefsen DM; Majerus PW
    J Clin Invest; 1975 Jun; 55(6):1259-68. PubMed ID: 1169259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets.
    Sekiya K; Okuda H
    Biochim Biophys Acta; 1984 Mar; 797(3):348-53. PubMed ID: 6320905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase.
    Lagarde M; Byron PA; Vargaftig BB; Dechavanne M
    Br J Haematol; 1978 Feb; 38(2):251-66. PubMed ID: 205238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmin inhibition of thrombin-induced platelet aggregation.
    Miller JL; Katz AJ; Feinstein MB
    Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perturbation of human endothelial cells by thrombin or PMA changes the reactivity of their extracellular matrix towards platelets.
    de Groot PG; Reinders JH; Sixma JJ
    J Cell Biol; 1987 Mar; 104(3):697-704. PubMed ID: 3818796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of thrombin activity by prothrombin activation fragment 1.2.
    Dasgupta SK; Thiagarajan P
    J Thromb Thrombolysis; 2007 Oct; 24(2):157-62. PubMed ID: 17334934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired platelet aggregation and thromboxane generation in essential fatty acid-deficient rats.
    Takahashi R; Manku MS; Horrobin DF
    J Nutr; 1987 Sep; 117(9):1520-6. PubMed ID: 2888839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet and blood vessel arachidonate metabolism and interactions.
    Needleman P; Wyche A; Raz A
    J Clin Invest; 1979 Feb; 63(2):345-9. PubMed ID: 372240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen interaction with human platelets: effect of other coagulation factors, prostaglandins and platelet inhibitors.
    Al-Mondhiry H; Ballard JO; McGarvey V
    Thromb Res; 1983 Aug; 31(3):415-26. PubMed ID: 20217998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein IIb-IIIa and fibrinogen.
    Connellan JM; Thurlow PJ; Barlow B; Lowe M; McKenzie IF
    Thromb Haemost; 1986 Apr; 55(2):153-7. PubMed ID: 2940722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.